CRT 2017 : RENAL DENERVATION & HYPERTENSION THERAPIES - Trial Design Part II & Future Directions

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$14.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

RENAL DENERVATION & HYPERTENSION THERAPIES - Trial Design Part II & Future Directions

Featuring

Michael Weber
Thomas Luescher
Hiren Mistry
Felix Mahfoud
Atul Pathak

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$14.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

What Is the Optimal Device Trial Design for Hypertension Therapy? - Michael Weber

Is There an Unmet Need for Device Treatment for Moderate Hypertension? - Thomas Luescher

What Are the FDA Parameters for Successful Study Design for Device Approval for Hypertension Therapy? - Hiren Mistry

What Are the Primary Endpoints for Controlling Hypertension? Unattended or Attended Office, Ambulatory or Home BP? - Felix Mahfoud

US Preventive Services Task Force Recommendation on ABPM Rationale/Potential Implications - Michael Weber

How Do I Treat Today’s Patients With Resistant Hypertension in My Practice? - Thomas Luescher

Future Directions for Treatment of Hypertension - Atul Pathak

Target Audience

Learning Objectives

Loading Simple Education